Amgen Inc. / COMPANIES AND INSTITUTIONS MENTIONED Amgen Inc. / BERNSTEIN / BIOCENTURY PUBLICATIONS INC. / Cytokinetics Inc. / GlaxoSmithKline plc / D. / /
Country
United Kingdom / /
Currency
USD / /
Event
Person Communication and Meetings / FDA Phase / Business Partnership / Layoffs / Reorganization / Product Issues / /
Facility
National Cancer Institute / / /
IndustryTerm
biology applications / skeletal and smooth muscle systems / platform technology / /
MedicalCondition
cuts / Asthma Cachexia Chronic / historically difficult diseases / ovarian cancers / obstructive pulmonary disease / COPD / lymphoma / expensive and uncertain cancer / 2000s a lot of cancer / arterial hypertension / ALS / solid tumors / amyotrophic lateral sclerosis / peripheral neuropathy / Claudication Pulmonary / melanoma / renal cell cancers / Strategy Leaving cancer / breast cancer / lung cancers / asthma / cancers / hypertension / bronchospasm / cancer / tumors / disease / chronic obstructive pulmonary disease / contraction / lateral sclerosis / heart failure / diseases / muscular dystrophies / stable disease / /
MedicalTreatment
chemo / chemotherapy / /
Organization
National Cancer Institute / /
Person
Robert Blum / Michael Flanagan / KAREN BERNSTEIN / / /
Position
CEO / Writer / Chairman & Editor-in-Chief / President & CEO / candidate / with more close behind / Ph. Chairman & Editor-in-Chief / /
Product
one / SB-743921 / CK-1827452 / muscle contractility / /
ProvinceOrState
Maryland / California / /
SportsEvent
NHL / /
Technology
same technologies / pharmacokinetics / platform technology / chemotherapy / drug development / /
REPRINT FROM SEPTEMBER 22, 2008 BioCentury THE BERNSTEIN REPORT ON BIOBUSINESS ®